Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXoPERT EMERALD: Early Multi-cancer Study of EV's Ramen-AL Linked Diagnosis Clinical Study Protocol

NCT07186296 is registered in ClinicalTrials.gov with EXoPERT as lead sponsor.

NCT NCT07186296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07186296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXoPERT EMERALD: Early Multi-cancer Study of EV's Ramen-AL Linked Diagnosis Clinical Study Protocol
Lead sponsor
EXoPERT
Phase
Observational
Overall status
Recruiting
Start date
May 9, 2025
Completion date
August 31, 2026
Enrollment
1,400 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, lung cancer, ovarian cancer, pancreatic cancer